Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 15;121(42):e2403217121.
doi: 10.1073/pnas.2403217121. Epub 2024 Oct 8.

Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition

Aijun Liu #  1   2 , Yezhou Liu #  1 , Clàudia Llinàs Del Torrent Masachs #  3 , Weijia Zhang  1 , Leonardo Pardo  3 , Richard D Ye  1   4
Affiliations

Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition

Aijun Liu et al. Proc Natl Acad Sci U S A. .

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a viral G protein-coupled receptor, KSHV-GPCR, that contributes to KSHV immune evasion and pathogenesis of Kaposi's sarcoma. KSHV-GPCR shares a high similarity with CXC chemokine receptors CXCR2 and can be activated by selected chemokine ligands. Like other herpesvirus-encoded GPCRs, KSHV-GPCR is characterized by its constitutive activity by coupling to various G proteins. We investigated the structural basis of ligand-dependent and constitutive activation of KSHV-GPCR, obtaining high-resolution cryo-EM structures of KSHV-GPCR-Gi complexes with and without the bound CXCL1 chemokine. Analysis of the apo-KSHV-GPCR-Gi structure (2.81 Å) unraveled the involvement of extracellular loop 2 in constitutive activation of the receptor. In comparison, the CXCL1-bound KSHV-GPCR-Gi structure (3.01 Å) showed a two-site binding mode and provided detailed information of CXCL1 binding to a chemokine receptor. The dual activation mechanism employed by KSHV-GPCR represents an evolutionary adaptation for immune evasion and contributes to the pathogenesis of Kaposi's sarcoma. Together with results from functional assays that confirmed the structural models, these findings may help to develop therapeutic strategies for KSHV infection.

Keywords: CXCL1; KSHV-GPCR; Kaposi’s sarcoma; chemokine; cryo-EM structure.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:The authors declare no competing interest.

Similar articles

See all similar articles

References

    1. Karamanou M., Antoniou C., Stratigos A. J., Saridaki Z., Androutsos G., The eminent dermatologist Moriz Kaposi (1837–1902) and the first description of idiopathic multiple pigmented sarcoma of the skin. J. BUON 18, 1101–1105 (2013). - PubMed
    1. Mesri E. A., Cesarman E., Boshoff C., Kaposi’s sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10, 707–719 (2010). - PMC - PubMed
    1. Goncalves P. H., Ziegelbauer J., Uldrick T. S., Yarchoan R., Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr. Opin. HIV AIDS 12, 47–56 (2017). - PMC - PubMed
    1. Moore P. S., Boshoff C., Weiss R. A., Chang Y., Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739–1744 (1996). - PubMed
    1. De Groof T. W. M., et al. , Viral G protein-coupled receptors: Attractive targets for herpesvirus-associated diseases. Pharmacol. Rev. 73, 828–846 (2021). - PubMed

MeSH terms

LinkOut - more resources